Blog
0
Screening and Diagnosis of Prostate Cancer
0

Reginald Tucker-Seeley, MA, ScM, ScD, gives an overview of the screening and diagnosis process of prostate cancer.

0
Scotland can be a cancer research powerhouse – Cancer Research UK
0

Every year in Scotland, 34,100 people are given the news that nobody wants to hear: “I’m sorry, you have cancer.”   These words turn lives upside down, ...

0
Novel Lung Cancer Vaccine Improves Survival With ‘Minor Side Effects’
0

The novel vaccine, Tedopi, improved both efficacy for survival and the drug’s safety profile for patients with non-small cell lung cancer (NSCLC), according ...

0
Maintaining Healthy Lifestyles in Young Adult Cancer Survivors
0

Young adult cancer survivors with mental health struggles, such as anxiety, stress and depression, may be more likely to have increased sugar intake and ...

0
October No. 9 With Metastatic Breast Cancer
0

For a few months before October, I think a lot about Breast Cancer Awareness Month. I wonder what nonprofit organizations have planned to draw attention to ...

0
CURE’s Audience Discusses Cancer Awareness Months
0

Most cancers and diseases have awareness months or weeks tied to them, and while they can be good to fundraise or educate people about the disease, not all ...

0
Welireg Granted Priority Review for Previously Treated Kidney Cancer
0

The Food and Drug Administration (FDA) granted a priority review for a supplemental new drug application to Welireg (belzutifan) for the treatment of adults ...

0
CRUK’s largest ever investment in Scotland bolsters institute science – Cancer Research UK
0

CRUK will award up to £123 million over a seven-year funding commitment to the Beatson Institute. The investment will bolster Scotland as a major global ...

0
Cancer Research UK announces largest ever investment in Scotland – Cancer Research UK
0

“But mum was brilliant. She’d come to stay, make dinner for my boys if I didn’t feel great, help keep things ticking along and just listen if I wanted ...

0
Imfinzi Plus Radiotherapy Is ‘Promising’ for Certain Patients With NSCLC
0

Imfinzi (durvalumab) combined with radiotherapy suggests promising results for certain patients with non-small cell lung cancer (NSCLC), according to ...

0
Reblozyl is a ‘Better First-Line Therapy’ for Anemia in MDS Subset
0

Treatment with Reblozyl (luspatercept-aamt) was recently approved by the U.S. Food and Drug Administration (FDA) for anemia (low red blood cell count) in ...

0
‘Incredible’ Impact of Integrative Medicine for Patients with Cancer at City of Hope
0

Diane Miller, a patient with stage 4 lung cancer, was able to gain a sense of calm and control thanks to her utilization of integrative medicine techniques ...

CML Alliance
Logo
Enable registration in settings - general
Compare items
  • Total (0)
Compare
0
Shopping cart